Interaction between C1-INA, coagulation, fibrinolysis and kinin system in hereditary angioneurotic edema (HANE) and urticaria. 1984

K Bork, and G Witzke, and K Artmann, and P Benes, and M Böckers, and W Kreuz

The C1-inactivator plays an important role not only in the initial phases of the complement system, but also in those of the coagulation, fibrinolysis and kinin systems. The present study was concerned with the reciprocal influence of decreased C1-inactivator levels in patients with hereditary angioneurotic edema (HANE, HAE). In 13 HANE-I patients there were significantly increased levels of the coagulation factors XII, XI, V, of plasminogen and of alpha 2-antiplasmin, while the factors IX and VII were decreased. Conversely, it emerged that in patients with markedly raised prephase factor levels, angioneurotic edema occurred in the presence of normal or only slightly decreased C1-inactivator levels. However, the ratio between factor XI and C1-INA activity was significantly higher than in normal and urticaria patients. Factor XII, HMWK, XI, VIII and V levels were significantly raised in 10 patients with frank chronic urticaria, while factor VII was lowered. Numerous other factors and inhibitors of the coagulation, fibrinolysis and kinin systems were, however, normal or showed no significant differences.

UI MeSH Term Description Entries
D007705 Kinins A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p588) Kinin
D001779 Blood Coagulation Factors Endogenous substances, usually proteins, that are involved in the blood coagulation process. Clotting Factor,Coagulation Factors,Blood Coagulation Factor,Clotting Factors,Coagulation Factor,Coagulation Factor, Blood,Coagulation Factors, Blood,Factor, Coagulation,Factors, Coagulation,Factor, Blood Coagulation,Factor, Clotting,Factors, Blood Coagulation,Factors, Clotting
D003174 Complement C1 Inactivator Proteins Serum proteins that inhibit, antagonize, or inactivate COMPLEMENT C1 or its subunits. Complement 1 Esterase Inhibitors,Complement C1 Inactivating Proteins,Complement C1 Inhibiting Proteins,Complement C1 Inhibitor Proteins,Complement C1r Protease Inhibitor Proteins,Complement C1s Esterase Inhibitor Proteins,Complement Component 1 Inactivator Proteins
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000799 Angioedema Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx. Quincke's Edema,Urticaria, Giant,Angioneurotic Edema,Angioedemas,Angioneurotic Edemas,Edema, Angioneurotic,Edema, Quincke's,Edemas, Angioneurotic,Giant Urticaria,Giant Urticarias,Quincke Edema,Quinckes Edema,Urticarias, Giant
D014581 Urticaria A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress. Hives,Urticarial Wheals,Urticarial Wheal,Urticarias,Wheal, Urticarial,Wheals, Urticarial

Related Publications

K Bork, and G Witzke, and K Artmann, and P Benes, and M Böckers, and W Kreuz
January 1973, International archives of allergy and applied immunology,
K Bork, and G Witzke, and K Artmann, and P Benes, and M Böckers, and W Kreuz
January 1983, Duodecim; laaketieteellinen aikakauskirja,
K Bork, and G Witzke, and K Artmann, and P Benes, and M Böckers, and W Kreuz
September 1986, The Journal of allergy and clinical immunology,
K Bork, and G Witzke, and K Artmann, and P Benes, and M Böckers, and W Kreuz
February 1977, Tissue antigens,
K Bork, and G Witzke, and K Artmann, and P Benes, and M Böckers, and W Kreuz
May 1976, Clinical immunology and immunopathology,
K Bork, and G Witzke, and K Artmann, and P Benes, and M Böckers, and W Kreuz
August 1983, Rinsho byori. The Japanese journal of clinical pathology,
K Bork, and G Witzke, and K Artmann, and P Benes, and M Böckers, and W Kreuz
January 1988, Annual review of immunology,
K Bork, and G Witzke, and K Artmann, and P Benes, and M Böckers, and W Kreuz
January 1983, Advances in experimental medicine and biology,
K Bork, and G Witzke, and K Artmann, and P Benes, and M Böckers, and W Kreuz
May 1982, Mayo Clinic proceedings,
K Bork, and G Witzke, and K Artmann, and P Benes, and M Böckers, and W Kreuz
July 1989, Behring Institute Mitteilungen,
Copied contents to your clipboard!